학술논문
Efficacy and safety of the oral Janus kinase inhibitor baricitinib in the treatment of adults with alopecia areata: Phase 2 results from a randomized controlled study
Document Type
Article
Author
Source
In Journal of the American Academy of Dermatology October 2021 85(4):847-853
Subject
Language
ISSN
0190-9622